Crossmark Global Holdings Inc. bought a new position in INC Research Holdings, Inc. (NASDAQ:INCR) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 8,580 shares of the company’s stock, valued at approximately $449,000.
A number of other hedge funds also recently modified their holdings of the stock. First Quadrant L P CA boosted its holdings in INC Research Holdings by 20,678.2% in the third quarter. First Quadrant L P CA now owns 80,204 shares of the company’s stock worth $4,195,000 after purchasing an additional 79,818 shares during the last quarter. Lee Thomas H Partners LP bought a new position in INC Research Holdings in the third quarter worth approximately $1,316,644,000. First Trust Advisors LP raised its position in INC Research Holdings by 61.3% in the third quarter. First Trust Advisors LP now owns 95,668 shares of the company’s stock worth $5,003,000 after acquiring an additional 36,355 shares during the period. Nationwide Fund Advisors raised its position in INC Research Holdings by 9.5% in the third quarter. Nationwide Fund Advisors now owns 167,803 shares of the company’s stock worth $8,776,000 after acquiring an additional 14,533 shares during the period. Finally, Personal Capital Advisors Corp bought a new position in INC Research Holdings in the third quarter worth approximately $234,000. Institutional investors own 78.78% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “8,580 Shares in INC Research Holdings, Inc. (INCR) Acquired by Crossmark Global Holdings Inc.” was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2017/11/22/8580-shares-in-inc-research-holdings-inc-incr-acquired-by-crossmark-global-holdings-inc.html.
Several brokerages have recently commented on INCR. TheStreet upgraded shares of INC Research Holdings from a “c” rating to a “b-” rating in a research report on Monday, November 6th. Jefferies Group LLC restated a “hold” rating and set a $62.50 price objective on shares of INC Research Holdings in a research report on Sunday, July 30th. Goldman Sachs Group, Inc. (The) restated a “buy” rating and set a $65.00 price objective on shares of INC Research Holdings in a research report on Monday, August 7th. Credit Suisse Group began coverage on shares of INC Research Holdings in a research note on Wednesday, October 11th. They set an “outperform” rating and a $68.00 target price for the company. Finally, Robert W. Baird reaffirmed a “buy” rating and set a $67.00 target price on shares of INC Research Holdings in a research note on Monday, October 9th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $56.33.
In related news, CFO Gregory S. Rush sold 41,420 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $58.26, for a total transaction of $2,413,129.20. Following the completion of the transaction, the chief financial officer now owns 42,793 shares in the company, valued at approximately $2,493,120.18. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Christopher L. Gaenzle sold 42,601 shares of the business’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $58.67, for a total transaction of $2,499,400.67. Following the transaction, the chief accounting officer now owns 69,557 shares of the company’s stock, valued at approximately $4,080,909.19. The disclosure for this sale can be found here. In the last quarter, insiders have sold 189,493 shares of company stock valued at $11,059,514. 0.24% of the stock is currently owned by company insiders.
Shares of INC Research Holdings, Inc. (NASDAQ:INCR) opened at $37.30 on Wednesday. INC Research Holdings, Inc. has a twelve month low of $33.60 and a twelve month high of $61.10. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.99. The firm has a market cap of $3,881.63, a PE ratio of 17.06, a P/E/G ratio of 1.17 and a beta of 1.36.
INC Research Holdings (NASDAQ:INCR) last posted its quarterly earnings results on Thursday, November 9th. The company reported $0.54 EPS for the quarter, missing the consensus estimate of $0.63 by ($0.09). INC Research Holdings had a negative net margin of 4.29% and a positive return on equity of 14.42%. The business had revenue of $592.21 million during the quarter, compared to the consensus estimate of $604.95 million. During the same quarter in the prior year, the firm posted $0.64 EPS. The company’s revenue for the quarter was up 128.2% compared to the same quarter last year. equities analysts forecast that INC Research Holdings, Inc. will post 2.15 earnings per share for the current fiscal year.
About INC Research Holdings
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for INC Research Holdings, Inc. (NASDAQ:INCR).
Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.